Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

While Washington Stews, You Can Cash In on the Biggest "Tax-Inversion" Deal in History

Back in June 2012, we recommended that you pick up shares of Big Pharma player Abbott Laboratories Inc. (NYSE: ABT). The reason: Abbott was planning to split in two at the end of the year, meaning folks who took our advice would end up with stakes in two companies for the price of one.

There was more than bargain-basement thinking at work here.

You see, these corporate breakups – known as spin-offs – have a habit of turning into market-beating profit plays. And the newly minted spin-off firms often end up as takeover fodder – also at big profits.

Abbott followed part of that blueprint.

  • Featured Story

    Hot Stocks: Vestas Wind Systems A/S (PINK:VWDRY) Could Bounce Back in 2011

    Danish wind turbine maker Vestas Wind Systems A/S (PINK ADR: VWDRY) has been racking up an impressive number of new orders lately - especially in the burgeoning Chinese market. Combined with several new manufacturing plants that will increase capacity in the United States, the surge should boost the company's performance in 2011.

    Vestas, the world's biggest maker of wind turbines, said last week that its orders from China last year reached a record high.

    "In 2010, Vestas has announced almost 1,000 megawatts (MW) worth of orders in China alone, which is a record high order intake for Vestas in this competitive market," the company said in a statement announcing an order from Chongli Construction Investment Huashi Wind Power Company Ltd.

    Vestas got an order for 58 turbines with total capacity of 49.3 megawatts from Chongli China and logged multiple orders from Germany in the past week.


    Read More...
  • Wind